APA

Depatureaux A., Leoz M., Le Moal G., Pathé J., Pavie J., Batisse D., Daneluzzi V., Genet P., Gerard L., Lascaux-Cametz A., Lambolez T., Chennebault J. & Plantier J. (20121031). Raltegravir-based regimens are effective in HIV-1 group O-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Depatureaux Agnès, Leoz Marie, Le Moal Gwenae, Pathé Jean-Paul, Pavie Juliette, Batisse Dominique, Daneluzzi Vincent, Genet Philippe, Gerard Laurence, Lascaux-Cametz Anne-Sophie, Lambolez Tessa, Chennebault Jean-Marie and Plantier Jean-Christophe. 20121031. Raltegravir-based regimens are effective in HIV-1 group O-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Depatureaux A., Leoz M., Le Moal G., Pathé J., Pavie J., Batisse D., Daneluzzi V., Genet P., Gerard L., Lascaux-Cametz A., Lambolez T., Chennebault J. and Plantier J. (20121031). Raltegravir-based regimens are effective in HIV-1 group O-infected patients. : Journal of acquired immune deficiency syndromes (1999).

MLA

Depatureaux Agnès, Leoz Marie, Le Moal Gwenae, Pathé Jean-Paul, Pavie Juliette, Batisse Dominique, Daneluzzi Vincent, Genet Philippe, Gerard Laurence, Lascaux-Cametz Anne-Sophie, Lambolez Tessa, Chennebault Jean-Marie and Plantier Jean-Christophe. Raltegravir-based regimens are effective in HIV-1 group O-infected patients. : Journal of acquired immune deficiency syndromes (1999). 20121031.